Nueva prueba para detectar malaria, illumigene® Malaria, establece una nueva regla de oro para el diagnóstico
January 27, 2016 01:30 ET
|
Meridian Bioscience Inc.
CINCINNATI, Jan. 27, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) anunció hoy que recibió la Marca CE para illumigene® Malaria, una novedosa prueba, de alta...
Ujian Malaria Terbaharu, illumigene® Malaria, Menetapkan Standard Emas Baru bagi Diagnosis
January 27, 2016 01:30 ET
|
Meridian Bioscience Inc.
CINCINNATI, Jan. 27, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) hari ini mengumumkan bahawa mereka telah menerima CE Mark bagi illumigene® Malaria, satu ujian baru...
新しいマラリア検査、イルミジーン・マラリア（illumigene® Malaria）がマラリア診断のゴールド・スタンダードを打ち立てる
January 27, 2016 01:30 ET
|
Meridian Bioscience Inc.
シンシナティ発, Jan. 27, 2016 (GLOBE NEWSWIRE) -- メリディアン･バイオサイエンス（Meridian Bioscience, Inc.、NASDAQ:VIVO）は本日、米国疾病管理予防センター（Centers for Disease Control and...
新瘧疾測試方法illumigene® Malaria建立全新的黃金診斷標準
January 27, 2016 01:30 ET
|
Meridian Bioscience Inc.
辛辛那提, Jan. 27, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience,...
말라리아 테스트인 일루미진 말라리아,진단 분야 새로운 표준 확립
January 27, 2016 01:30 ET
|
Meridian Bioscience Inc.
미국 신시내티, Jan. 27, 2016 (GLOBE NEWSWIRE) -- 메리디안 바이오사이언스(Meridian Bioscience, Inc.)는 고도의 정확성을 갖춘 새로운 형태의 테스트인 일루미진 말라리아(illumigene® Malaria)가 CE마크를 획득했다고 발표했다. 본 테스트는 미국 질병통제예방센터(CDC)와 세네갈...
新疟疾测试方法illumigene® Malaria建立全新的黄金诊断标准
January 27, 2016 01:30 ET
|
Meridian Bioscience Inc.
辛辛那提, Jan. 27, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience,...
Meridian Bioscience and Lean Continuous Improvements, LLC Collaborate to Apply Lean Principles to Recent Launch of illumigene® Malaria
January 26, 2016 10:00 ET
|
Meridian Bioscience Inc.
CINCINNATI, Jan. 26, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. announced today that the recent product transfer and launch of its innovative molecular test illumigene® Malaria was...
New Malaria Test, illumigene® Malaria, Sets a New Gold Standard for Diagnosis
January 26, 2016 07:30 ET
|
Meridian Bioscience Inc.
CINCINNATI, Jan. 26, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that it has received the CE Mark for illumigene® Malaria, a novel, highly...